FindTrial
Sign In

Clinical trial of lipoprotein-associated phospholipase A2(Lp-PLA2) assay kit (continuous monitoring method)

Clinical trial of lipoprotein-associated phospholipase A2(Lp-PLA2) assay kit (continuous monitoring method)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034062
Enrollment
Unknown
Registered
2020-06-22
Start date
2020-06-15
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Gold Standard:Comparison of similar kits
Continuous monitoring method
Index test:lipoprotein-related&#32
phospholipase&#32
A2(Lp-PLA2)&#32
assay&#32
kit&#32
(continuous&#32
monitoring&#32
method)

Sponsors

Shanghai Xuhui District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Activity of Lp-PLA2 1) Male activity 670 u/l not less than 15 cases 2) female activity 535 u/l no less than 15 cases

Exclusion criteria

Exclusion criteria: 1) The sample size is not enough for detection; 2) extreme hemolysis and extreme lipemia samples; 3) The main researcher determines that it does not meet the selection criteria.

Design outcomes

Primary

MeasureTime frame
Activity of Lp-PLA2;—

Countries

China

Contacts

Public ContactYunxiao Song

Department of Clinical Laboratory, Xuhui District Central Hospital

xzxsh@sina.com+86 021 31270810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026